Hvordan bør vi udnytte mulighederne foranalyse af registre og sundhedsdata i fremtiden?
Upcoming SlideShare
Loading in...5
×
 

Hvordan bør vi udnytte mulighederne for analyse af registre og sundhedsdata i fremtiden?

on

  • 72 views

 

Statistics

Views

Total Views
72
Views on SlideShare
72
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Hvordan bør vi udnytte mulighederne foranalyse af registre og sundhedsdata i fremtiden? Hvordan bør vi udnytte mulighederne for analyse af registre og sundhedsdata i fremtiden? Presentation Transcript

    • Hvordan bør vi udnytte mulighederne for analyse af registre og sundhedsdata i fremtiden? Lars Juhl Jensen
    • strukturerede data
    • Jensen et al., Nature Reviews Genetics, 2012
    • ustrukturerede data
    • tekstmining
    • computer
    • smart som en hund
    • ordbog
    • bivirkninger
    • lægemidler
    • Clozapine clozapi n clossapi n klozapin e chlosapi n chlosapi ne chlozapi n chlozapi ne klossapi n closapin e klozapi nklosapi n
    • kan det gavne patienter?
    • bivirkningsovervågning
    • Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuationAdverse event Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction ADR of additional drug
    • Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuationAdverse eventIdentification start Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction ADR of additional drug
    • Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuation Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction Adverse event ADR of additional drug Identification start
    • Eriksson et al., Drug Safety, 2014 Drug introduction Drug discontinuation Adverse eventNegative modifier Indication Pre-existing condition Adverse drug reaction Possible adverse drug reaction Adverse event ADR of additional drug Identification start
    • statistik
    • nye bivirkninger
    • hyppighed
    • Eriksson et al., Drug Safety, 2014
    • heterogen IT infrastruktur
    • sygdomstrajektorier
    • Landspatientregistret
    • Jensen et al., Nature Reviews Genetics, 2012
    • dslige sygdomskorrelatione
    • trajektorier
    • Jensen et al., Nature Communications, 2014
    • trajektorienetværk
    • Jensen et al., Nature Communications, 2014
    • centrale diagnoser
    • Jensen et al., Nature Communications, 2014
    • confounding
    • alder og køn
    • Jensen et al., Nature Communications, 2014
    • livsstil
    • undersøgelsesbias
    • udfordringer
    • standardisering af data
    • løbende data opdatering
    • integration med hospitaler
    • Mange tak! Bivirkninger Robert Eriksson Thomas Werge Søren Brunak Sygdomstrajektorier Anders Bøck Jensen Tudor Oprea Pope Moseley Søren Brunak Tekstmining Peter Bjødstrup Jensen Robert Eriksson Henriette Schmock Francisco S. Roque Anders Juul Marlene Dalgaard Massimo Andreatta Sune Frankild Eva Roitmann Thomas Hansen Karen Søeby Søren Bredkjær Thomas Werge Søren Brunak